蒽环类药物
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| —— | 14-Salicyloylcarubicin | 116907-26-7 | C33H31NO13 |
| —— | 5,12-Naphthacenedione, 8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(4-morpholinyl)-alpha-L-lyxo-hexopyranosyl)oxy)- | 80875-73-6 | C31H37NO12 |
| —— | 5,12-Naphthacenedione, 8-((butylthio)acetyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)- | 83311-77-7 | C33H36F3NO11S |
| —— | 14-(Carbethoxymethyl)-14-thiaadriamycin | 83291-68-3 | C31H35NO12S |
| —— | N-(Trifluoroacetyl)-14-dodecyl-14-thiaadriamycin | 83291-70-7 | C41H52F3NO11S |
| —— | 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-4-O-methyl-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)- | 82950-94-5 | C28H31NO10 |
| —— | S,S-Bis(daunorubicin-14-yl)ethane-1,2-dithiol | 83291-73-0 | C56H60N2O20S2 |
| —— | S,S-Bis(daunorubicin-14-yl)nonane-1,2-dithiol | 83291-76-3 | C63H74N2O20S2 |
| —— | 14-Phenyl-14-selenaadriamycin | 83291-72-9 | C33H33NO10Se |
| —— | S,S-Bis(daunorubicin-14-yl)hexane-1,2-dithiol | 83291-75-2 | C60H68N2O20S2 |
| —— | 14-Phenyl-14-thiaadriamycin | 83291-67-2 | C33H33NO10S |
| —— | 14-Butyl-14-thiaadriamycin | 83291-64-9 | C31H37NO10S |
| —— | N-(Trifluoroacetyl)-14-thiaadriamycin | 83291-69-4 | C34H38F3NO11S |
| —— | 14-Pentyl-14-thiaadriamycin | 83291-65-0 | C32H39NO10S |
| —— | S,S-Bis(daunorubicin-14-yl)propane-1,2-dithiol | 83291-74-1 | C57H62N2O20S2 |
| —— | Daunomycinone-S | 80930-61-6 | C35H43NO13 |
| —— | 2-Hydroxyaclacinomycin T | 80839-98-1 | C30H35NO11 |
| —— | 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-3,5-dideoxy-beta-D-ribofuranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)- | 79898-13-8 | C26H28ClNO10 |
| —— | Daunomycinone-L | 80930-62-7 | C40H49NO15 |
| —— | (7S,9S)-9-acetyl-7-[(2S,3R,4S,5R)-4-amino-3-hydroxy-5-methyloxolan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydron;chloride | —— | C26H28ClNO10 |
| —— | 8-(1,2-Dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(4-morpholinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-5,12-naphthacenedione hydrochloride | 80787-27-5 | C31H38ClNO12 |
| —— | 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((tetrahydro-2H-pyran-4-yl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, hydrochloride, (8S-cis)- | 79898-10-5 | C32H38ClNO11 |
| —— | Daunomycinone-K | 80930-63-8 | C39H47NO15 |
| —— | alpha2-Rmn-A | 80930-58-1 | C40H51NO15 |
| —— | 2-Hydroxyaclacinomycin S | 80839-97-0 | C36H45NO14 |
| —— | 4-O-Methylaclacinomycin S | 79146-62-6 | C37H47NO13 |
| —— | Daunomycinone-A | 80930-60-5 | C41H51NO15 |
| —— | beta-Isorhodomycinone | 80930-57-0 | C40H51NO16 |
| —— | 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(4-methoxy-1-piperidinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-, hydrochloride, (8S-cis)- | 79898-14-9 | C33H40ClNO11 |
| —— | 4-O-Methylaclacinomycin N | 79146-61-5 | C43H57NO15 |
| —— | 13-Methylaclacinomycin T | 78776-22-4 | C31H37NO10 |
| —— | 6-Methoxydaunomycin | 78008-04-5 | C28H31NO10 |
| —— | 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-((phenylseleno)acetyl)-10-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)- | 77270-19-0 | C35H32F3NO11Se |
| —— | 10-epi-Aclacinomycin A | 77448-81-8 | C42H53NO15 |
| —— | 5,12-Naphthacenedione, 8-acetyl-10-((3-(((4S)-4-amino-4-carboxy-1-oxobutyl)amino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)- | 106372-52-5 | C32H36N2O13 |
| —— | 8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-(1-piperidinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-5,12-naphthacenedione hydrochloride, (8S-cis)- | 74985-07-2 | C32H38ClNO10 |
| —— | 2'-Bromo-4'-epidaunorubicin | 155029-34-8 | C27H28BrNO10 |
| —— | 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-D-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)- | 75444-30-3 | C27H29NO10 |
| —— | 8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((N-L-leucyl-L-leucyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-5,12-naphthacenedione monohydrochloride, (8S-cis)- | 74853-78-4 | C39H52ClN3O12 |
| —— | 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-1-methoxy-, hydrochloride, (8R-trans)- | 73068-99-2 | C27H30ClNO9 |
| —— | dibenzyldaunorubicin | 69230-47-3 | C41H41NO10 |
| —— | Acetic acid, hydroxy-, 2-(4-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl)-2-oxoethyl ester, (2S-cis)- | 76095-18-6 | C29H31NO13 |
| —— | 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((N-L-leucyl-L-alanyl)amino)-alpha-L-xylo-hexopyranosyl)oxy)-, monohydrochloride, (8S-cis)- | 74853-79-5 | C36H46ClN3O12 |
| —— | 10-((3-(Acetylamino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione hydrochloride, (8S-cis)- | 73068-97-0 | C29H32ClNO12 |
| —— | N-[6-[(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl)oxy]-3-hydroxy-2-methyloxan-4-yl]-2-[(2-aminoacetyl)amino]-4-methylpentanamide;hydron;chloride | —— | C35H44ClN3O12 |
| —— | L-Valyldaunorubicin HCl | 74853-76-2 | C32H39ClN2O11 |
| —— | 7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(1-piperidinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-5,12-naphthacenedione hydrochloride, (8S-cis)- | 74985-08-3 | C32H40ClNO10 |
| —— | 4'-O-Methyldaunorubicin hydrochloride | 68102-49-8 | C28H32ClNO10 |
| —— | epsilon-ISORMN-A | 76264-94-3 | C42H53NO17 |
| —— | L-Isoleucyldaunorubin HCl | 74853-77-3 | C33H41ClN2O11 |
联系我们
关注我们
公众号
